Advanced Biomedical Research Center, Dokuz Eylul University , Izmir , Turkey ; Department of Neuroscience, Health Science Institute, Dokuz Eylul University , Izmir , Turkey.
Department of Neuroscience, Health Science Institute, Dokuz Eylul University , Izmir , Turkey.
Front Immunol. 2014 Sep 30;5:475. doi: 10.3389/fimmu.2014.00475. eCollection 2014.
Erythropoietin (EPO) is a neuroprotective cytokine, which has been applied in several animal models presenting neurological disorders. One of the proposed modes of action resulting in neuroprotection is post-transcriptional gene expression regulation. This directly brings to mind microRNAs (miRNAs), which are small non-coding RNAs that regulate gene expression at the post-transcriptional level. It has not yet been evaluated whether miRNAs participate in the biological effects of EPO or whether it, inversely, modulates specific miRNAs in neuronal cells. In this study, we employed miRNA and mRNA arrays to identify how EPO exerts its biological function. Notably, miR-451 and miR-885-5p are downregulated in EPO-treated SH-SY5Y neuronal-like cells. Accordingly, target prediction and transcriptome analysis of cells treated with EPO revealed an alteration of the expression of genes involved in apoptosis, cell survival, proliferation, and migration. Low expression of miRNAs in SH-SY5Y was correlated with high expression of their target genes, vascular endothelial growth factor A, matrix metallo peptidase 9 (MMP9), cyclin-dependent kinase 2 (CDK2), erythropoietin receptor, Mini chromosome maintenance complex 5 (MCM5), B-cell lymphoma 2 (BCL2), and Galanin (GAL). Cell viability, apoptosis, proliferation, and migration assays were carried out for functional analysis after transfection with miRNA mimics, which inhibited some biological actions of EPO such as neuroprotection, anti-oxidation, anti-apoptosis, and migratory effects. In this study, we report for the first time that EPO downregulates the expression of miRNAs (miR-451 and miR-885-5p) in SH-SY5Y neuronal-like cells. The correlation between the over-expression of miRNAs and the decrease in EPO-mediated biological effects suggests that miR-451 and miR-885-5p may play a key role in the mediation of biological function.
促红细胞生成素(EPO)是一种神经保护细胞因子,已在几种出现神经紊乱的动物模型中得到应用。导致神经保护的一种提议作用模式是转录后基因表达调控。这直接让人想到微小 RNA(miRNA),它们是一种小的非编码 RNA,可在转录后水平调节基因表达。目前还没有评估 miRNA 是否参与 EPO 的生物学效应,或者反之,EPO 是否调节神经元细胞中的特定 miRNA。在这项研究中,我们采用 miRNA 和 mRNA 阵列来确定 EPO 如何发挥其生物学功能。值得注意的是,miR-451 和 miR-885-5p 在 EPO 处理的 SH-SY5Y 神经元样细胞中下调。相应地,用 EPO 处理的细胞的靶预测和转录组分析显示,参与细胞凋亡、细胞存活、增殖和迁移的基因的表达发生改变。miRNA 在 SH-SY5Y 中的低表达与它们的靶基因血管内皮生长因子 A、基质金属蛋白酶 9(MMP9)、细胞周期蛋白依赖性激酶 2(CDK2)、促红细胞生成素受体、微型染色体维持复合物 5(MCM5)、B 细胞淋巴瘤 2(BCL2)和甘丙肽(GAL)的高表达相关。转染 miRNA 模拟物后进行细胞活力、细胞凋亡、增殖和迁移测定,以进行功能分析,这些模拟物抑制了 EPO 的一些生物学作用,如神经保护、抗氧化、抗凋亡和迁移作用。在这项研究中,我们首次报道 EPO 下调 SH-SY5Y 神经元样细胞中 miRNA(miR-451 和 miR-885-5p)的表达。miRNA 过表达与 EPO 介导的生物学效应降低之间的相关性表明,miR-451 和 miR-885-5p 可能在介导生物学功能中发挥关键作用。